Amphotericin B prophylaxis against invasive fungal infections in neutropenic patients: A single center experience from 1980 to 1995

Infection

Volumn 24, Issue 5, 1996, Pages 361-366

  De Laurenzi, A ^a   Matteocci, A ^a   Lanti, A ^a   Pescador, L ^a   Blandino, F ^a   Papetti, C ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPERGILLOSIS; CANDIDIASIS; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HIGH RISK PATIENT; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ITALY; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PROPHYLAXIS; RETROSPECTIVE STUDY;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AMPHOTERICIN B; ASPERGILLOSIS; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MYCOSES; NEUTROPENIA; RETROSPECTIVE STUDIES; ROME;

EID: 0029908386     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01716080     Document Type: Article

References (16)

1. Meunier, F., Rubin, R. H., Young, L. S.: Fungal infections in the compromised host. In: Rubin, R. H., Young, L. S. (eds.): Clinical approach to the infections in the compromised host. 2nd ed. Plenum Medical, New York 1988, pp. 193-220.
2. Tollemar, J., Holmberg, K., Ringden, O., Lonnoqvist, B.: Surveillance test for the diagnosis of invasive fungal infections in bone marrow recipients. Scand. J. Infect. Dis. 21 (1989) 205-212.
3. Denning, D. W.: Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host. J. Antimicrob. Chemotherap. 28 (Suppl. B) (1991) 1-16.
4. Bodey, G. P., Bueltman, B., Duginald, W., Gibbs, D., Hanak, H., Hotchi, M., Mall, G., Martino, P., Meunier, F., Milliken, S., Naoe, S., Okudaira, M., Scevola, D., van't Wout, J.: Fungal infection in cancer patients: an international autopsy survey. Eur. J. Clin. Microbiol. Infect. Dis. 11 (1992) 99-109.
5. Schologl, E., Preiser, J., Baumgartner, G., Fiedler, E., Hanak, H., Heinz, R.: Mold-associated infections are increasing. Mycology Observer 2 (1993) 8.
6. Bodey, G. P., Buckeley, M., Sathe, Y. S., Freireich, E. J.: Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann. Intern. Med 64 (1966) 328-340.
7. Aisner, J., Murillo, J., Schimpff, S. C.: Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. Ann. Intern. Med. 90 (1979) 4-9.
8. Winston, D. J., Chandrasekar, P. H., Lazarus, H. M., Goodman, J. L., Silber, J. L., Horowitz, H., Shadduck, R. K., Rosenfeld, C. S., Ho, W. G., Islam, M. Z., Buell, D. N.: Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Ann. Intern. Med. 118 (1993) 495-503.
9. Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, P., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., Powderly, W. G., Silber, J. L., Horowitz, H., Lichtin, A., Wolff, S. N., Mangan, K. F., Silver, S. M., Weisdorf, D., Ho, W. G., Gilbert, G., Buell, D.: A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N. Eng. J. Med. 326 (1992) 845-851.
10. Persons, D. A., Laughlin, M., Tanner, D., Perfect, J., Gockerman, J. P., Hathorn, J. W.: Fluconazole and Candida krusei fungemia. N. Engl. J. Med. 325 (1991) 1315.
11. Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., Saral, R.: Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 325 (1991) 1274-1277.
12. Vreugdenhil, G., Van Dijke, B. J., Donnelly, P., Novakova, I. R., Raemaekers, J. M. M., Hoogkamp-Korstanje, M. A. A., Koster, M., De Pauw, B. E.: Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double-blind, placebo controlled study. Leuk. Lymphoma 11 (1994) 353-360.
13. Schwarz, S., Beyer, J., Benre, G., Lenz, K., Wandt, H., Grueisen, A., Trittin, A., Thiel, E.: Evaluation of aerosol amphotericin B for prophylaxis of invasive pulmonary aspergillosis in neutropenic patients. An interim analysis of a prospective, randomized trial. Blood 84 (Suppl. 1) (1994) abstr. 306 a.
14. O'Donnell, M. R., Schmidt, G. M., Tegtmeier, B. R., Faucett, C., Fohey, J. L., Ito, J., Nademanee, A., Niland, J., Parker, P., Smith, E. P., Snyder, D. S., Stein, A. S., Blume, K. G., Forman, S. J.: Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. J. Clin, Oncol. 12 (1994) 827-834.
15. Tollemar, J., Ringden, O., Andersson, S., Sundberg, B., Ljungman, P., Tyden, G.: Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients. Bone Marrow Transplantat. 12 (1993) 577-582.
16. Uzun, O., Anaissie, E. J.: Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal. Blood 86 (1995) 2063-2072.